tiprankstipranks
Rapport Therapeutics, Inc. (RAPP)
:RAPP
US Market

Rapport Therapeutics, Inc. (RAPP) Income Statement

Compare
23 Followers

Rapport Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Rapport Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q3, Rapport Therapeutics, Inc.'s net income was $-17.54M. See Rapport Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ -112.00K$ -15.00K
Operating Expenses
$ 36.07M$ 10.35M
Depreciation and Amortization
$ 112.00K$ 15.00K
EBITDA
$ -34.66M$ -10.35M
Operating Income
$ -36.18M$ -10.37M
Other Income/Expenses
$ 1.40M$ -285.00K
Pretax Income
$ -34.78M$ -10.65M
Net Income
$ -34.79M$ -10.65M
Per Share Metrics
$ ―$ ―
Basic EPS
$ -0.21$ -0.29
Diluted EPS
$ -0.21$ -0.29
Weighted Average Shares Outstanding
164.35M 36.58M
Weighted Average Shares Outstanding (Diluted)
164.35M 36.58M
Currency in USD

Rapport Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis